QR Code (код быстрого отклика)

Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study

Risk-adapted prostate cancer (PC) screening is currently based on a combination of prostate-specific antigen (PSA) testing, risk assessment, and magnetic resonance imaging (MRI). Classical venous blood sampling is usually performed by health care professionals, which may reduce participation in futu...

Полное описание

Сохранить в:
Главные авторы: Martin Wallisch, Peter Albers, Nikolaus Becker, Friedrich Boege, Derik Hermsen, Tanmay Ramesh Londhe, Jale Lakes, Jan Philipp Radtke, Agne Krilaviciute, Petra Seibold, Axel Benner, Maral Saadati, Stefan Holdenrieder, Rouvier Al-Monajjed
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2025-08-01
Серии:European Urology Open Science
Предметы:
Prostate cancer
Risk-adapted screening
Prostate-specific antigen
Capillary blood
Population-based screening
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S2666168325001259
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы